GlassScriptPhysician profile
Prasad Iyer
NPI 1770563298
$23,343.65
in general payments reported to CMS, 2019-2025
7 companies · $6,656 in 2025
The $6,656 reported for 2025 was more than what 91% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $13K · 2022: $1,931 · 2023: $2,000 · 2024: $85.08 · 2025: $6,656.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,000 · Food and Beverage: $741.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,000.00 |
| Food and Beverage | $740.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pentax of America, INC. | $9,935.84 | 2021-2025 | Pentax Medical, C2 Cryoballoon, C2 Cryoballoon Focal Controller |
| Ambu INC. | $6,946.75 | 2021 | |
| Medtronic, INC. | $4,313.42 | 2021-2022 | |
| Creo Medical INC. | $1,546.01 | 2022 | |
| Boston Scientific Corporation | $439.15 | 2021-2025 | Apollo Esg Nxt System, Overstitch Endoscopic Suturing System, Exalt Model D |
| Exact Sciences Corporation | $117.39 | 2024-2025 | |
| Phathom Pharmaceuticals, INC. | $45.09 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Prasad Iyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.